XTL BIOPHARMACEUTICALS LTD.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2020 | $2.9M | $6.5M | $3.6M |
| FY2021 | $1.3M | $6.6M | $3.0M |
| FY2022 | $187.0K | $4.2M | $2.1M |
| FY2023 | $206.0K | $2.4M | $1.4M |
| FY2024 | $3.1M | $5.8M | $371.0K |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2020 | $2.9M | $6.5M | $3.6M |
| FY2021 | $1.3M | $6.6M | $3.0M |
| FY2022 | $187.0K | $4.2M | $2.1M |
| FY2023 | $206.0K | $2.4M | $1.4M |
| FY2024 | $3.1M | $5.8M | $371.0K |